11/07/2022Published by Fondazione Gianni Bonadonna at 11/07/2022Categories Events UncategorizedEfficacy of nivolumab as neoadjuvant therapy in resectable lung cancer
04/07/2022Published by Fondazione Gianni Bonadonna at 04/07/2022Categories Events UncategorizedNeratinib and fulvestrant are active for HER2-mutated metastatic breast cancer
27/06/2022Published by Fondazione Gianni Bonadonna at 27/06/2022Categories Events UncategorizedActivity of olaparib in patients with BRCA-mutated early breast cancer
20/06/2022Published by Fondazione Gianni Bonadonna at 20/06/2022Categories Events UncategorizedA breakthrough in the treatment of advanced breast cancer
13/06/2022Published by Fondazione Gianni Bonadonna at 13/06/2022Categories Events UncategorizedFirst positive results with a CAR-T therapy plus pembrolizumab in malignant pleural mesothelioma
06/06/2022Published by Fondazione Gianni Bonadonna at 06/06/2022Categories Events UncategorizedBreast cancer regression with a trispecific antibody
30/05/2022Published by Fondazione Gianni Bonadonna at 30/05/2022Categories Events UncategorizedPromising results with alpesilib plus olaparib in advanced triple-negative breast cancer
23/05/2022Published by Fondazione Gianni Bonadonna at 23/05/2022Categories Events UncategorizedPromising antitumor activity of rucaparib and sacituzumab govitecan
16/05/2022Published by Fondazione Gianni Bonadonna at 16/05/2022Categories Events UncategorizedSafety and activity of the selective FGFR 1-3 inhibitor pemigatinib
